Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Onconetix (ONCO) Shares Outstanding (Diluted Average) (2023 - 2025)

Historic Shares Outstanding (Diluted Average) for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $1.4 million.

  • Onconetix's Shares Outstanding (Diluted Average) rose 904661.59% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 904661.59%. This contributed to the annual value of $2.7 million for FY2024, which is 54181.08% up from last year.
  • Onconetix's Shares Outstanding (Diluted Average) amounted to $1.4 million in Q3 2025, which was up 904661.59% from $567648.0 recorded in Q2 2025.
  • In the past 5 years, Onconetix's Shares Outstanding (Diluted Average) ranged from a high of $18.2 million in Q1 2025 and a low of $6528.0 during Q2 2024
  • Over the past 3 years, Onconetix's median Shares Outstanding (Diluted Average) value was $567648.0 (recorded in 2025), while the average stood at $5.1 million.
  • Per our database at Business Quant, Onconetix's Shares Outstanding (Diluted Average) tumbled by 9995.9% in 2024 and then soared by 904661.59% in 2025.
  • Quarter analysis of 3 years shows Onconetix's Shares Outstanding (Diluted Average) stood at $427784.0 in 2023, then skyrocketed by 541.81% to $2.7 million in 2024, then plummeted by 48.81% to $1.4 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $1.4 million in Q3 2025, compared to $567648.0 in Q2 2025 and $18.2 million in Q1 2025.